In the News Stocks: Hydrogenics (NASDAQ:HYGS), Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), Host Hotels & Resorts (NYSE:HST), BIND Therapeutics (NASDAQ:BIND), ImmunoGen (NASDAQ:IMGN)


Hydrogenics Corporation (NASDAQ:HYGS) shares increased 1.74% in last trading session and ended the day at $10.51. HYGS Gross Margin is 23.10% and its has a return on assets of -16.30%. Hydrogenics Corporation (NASDAQ:HYGS) quarterly performance is -11.98%. Equities research analysts at Roth Capital set a $15.00 price target on shares of Hydrogenics (NASDAQ:HYGS) stock in a research note issued to investors on Wednesday. The firm currently has a “buy” rating on the stock. Roth Capital’s target price would suggest a potential upside of 35.14% from the company’s current price.

Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) ended the last trading day at $22.98. Company weekly volatility is calculated as 5.02% and price to cash ratio as 7.61. Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) showed a weekly performance of -5.90%. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) announced that Rick Shea has advised the Company of his intention to step down as Chief Financial Officer (CFO) once a successor is identified and appointed. Mr. Shea will remain with the Company to assist with the CFO succession and serve in a newly created role of Senior Vice President, Corporate Communications and Operations for a transition period prior to his planned retirement in 2016. Momenta has initiated a CFO search.

On 25 June, Host Hotels & Resorts, Inc. (NYSE:HST) shares fell -2.07% and was closed at $20.30. HST EPS growth in last 5 year was 37.00%. Host Hotels & Resorts, Inc. (NYSE:HST) year to date (YTD) performance is -13.75%. Host Hotels & Resorts, Inc. (NYSE:HST) announced that its board of directors authorized a regular quarterly cash dividend of $0.20 per share on the Company’s common stock. The dividend is payable on July 15, 2015, to stockholders of record on June 30, 2015.

BIND Therapeutics, Inc. (NASDAQ:BIND) shares fell -4.05% in last trading session and ended the day at $5.68. BIND has a return on assets of -49.40%. BIND Therapeutics, Inc. (NASDAQ:BIND) quarterly performance is 4.80%. BIND Therapeutics, Inc. (NASDAQ:BIND), presented at the JMP Securities Life Sciences Conference 2015 on Tuesday, June 23, 2015 at 11:30 a.m. ET at the St. Regis hotel in New York City.

ImmunoGen, Inc. (NASDAQ:IMGN) caters to the Healthcare space. It has a net profit margin of -72.20% and weekly performance is -2.87%. On the last day of trading company shares ended up $14.22. ImmunoGen, Inc. (NASDAQ:IMGN) distance from 50-day simple moving average (SMA50) is 29.64%. ImmunoGen, Inc. (NASDAQ:IMGN), announced the first presentation of findings with the Company’s CD37-targeting ADC, IMGN529, in combination with the CD20-targeting antibody, rituximab (Rituxan®), in preclinical assessments.


Leave a Reply

Your email address will not be published. Required fields are marked *